MULTIPLE MYELOMA – How translational research transformed and
guides clinical practice and vice versa – For both scientists and clinicians
Chairs: Hermann Einsele, Martin Kaiser, Omar Nadeem, Sonja Zweegman
.avif)
MULTIPLE MYELOMA – How translational research transformed and
guides clinical practice and vice versa – For both scientists and clinicians
Our Chairs
Information
SAVE THE DATE:
February 25-27, 2027 - Vienna, Austria
Chairpersons: Hermann Einsele, Martin Kaiser, Omar Nadeem, Sonja Zweegman
#ESHMM2027
About the conference:
ESH is pleased to announce the launch of a new meeting dedicated to Multiple Myeloma, bringing together both clinical and translational perspectives, while actively involving young clinicians and scientists in the programme. This meeting combines basic science, translational science and clinical decision, making debates on hot topics in MM / SMM. They will include clinical case presentations and discussions, as well as keynote lectures on novel treatment approaches.
Main Scientific Topics:
• The non-smouldering developments in smouldering myeloma
• To treat or not to treat SMM
• The reality of CAR-T and BsAb therapy - sequencing matters!
• What to do first in first-line therapy - controversies
• CAR-T cells or Bispecifics?
• Moving earlier to T-cell therapies in early relapse
• How to treat in later lines when T-cell have become exhausted treating
• Gain greater insight through a deep and broad perspective: the role of deep sequencing and spatial transcriptomics
• Will we still do transplants in 2030
• Treatment endpoints in multiple myeloma
• Hot topics
The Programme will include:
• Plenary Sessions
• Keynote Lectures
• Interactive Case Presentations
• Flash Talks
• Tumour Boards
• Panel Discussions
• Debates
• Brief Oral Communications
• Poster Walks
• Meet the Expert Sessions
• Voting technology
• Ample time for in-depth discussions and networking
Learning Objectives:
• Plasma Cell Biology
• Treatment of newly diagnosed MM
• T Cell Exhaustion / T Cell Dysfunction
• Novel T-cell-based therapies
• Smouldering MM: Biology, Treatment Algorithms
• Treatment of relapsed/refractory MM
• Diagnosis and treatment of other Plasma Cell Dyscrasias
This conference is a Face to Face meeting. No virtual attendance is scheduled.
Programme
Read the preliminary programme!
Registration
REGISTRATION IS OPEN!
The registration fee for the ESH 1st conference on “Multiple Myeloma – From Bench to Bedside – for young and experienced scientists and clinicians” is:
• 600€ for fully trained
• 300€ for in-training *
• 300€ Allied Health Professionals
• 600€ for Corporate
*A proof will be requested to confirm your status.
ESH is pleased to offer BHS, BSH, DGHO, HSH, OeGHO, PTHiT, SEHH, SFH (French), SFH (Swedish) & SPH Members a 20% discount on the conference registration fees.
This fee includes:
• Your seat in the Conference Room
• The conference materials,
• Welcome cocktail, luncheons, refreshments throughout the conference.
Your seat in the conference will be definitively reserved upon receipt of your fee.
Cancellation policy of registration fee:
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA and MASTERCARD/EUROCARD.
Abstract submission
Call for abstracts and Clinical Cases!
Clinical cases and abstracts are eligible to be selected for a brief oral communication or a poster presentation.
Deadline for submission: December 13, 2026 (23:59 CET)
Clinical Case Presentation Guidelines:
1. Clinical cases must be relevant to the topic of the meeting.
2. Maximum number of words: 500
3. Your clinical case will be submitted to peer review.
Abstract Guidelines:
1. Your abstract can be structured (eg Objectives, Methods, Results, Conclusions) or unstructured.
2. Maximum number of words: 500
3. Your abstract will be submitted to peer review.
We accept “encore” abstract.
Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.
Venue
Austria Trend Hotel Savoyen
Rennweg 16
1030 Vienna
AUSTRIA
How to get there:
• From Vienna International Airport: Train ÖBB S7 to Wien Rennweg station - Travel time: 25 minutes
• From Vienna City Centre: Tramway line 71 to Rennweg - Travel time: 10 minutes
Accommodation
Austria Trend Hotel Savoyen
Rennweg 16
1030 Vienna
AUSTRIA
Warning!
We have detected scam activity of a company trying to sell accommodation services to the speakers of our conferences. Apparently, they have been collecting information on the speakers from the lists that are made public on our websites.
Please make sure you book your accommodation either via the link(s) provided by ESH on this page, or directly with the hotel or renown booking services platform
Corporate partners
With the support of*:
Level 1 Conference Partner
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.
.jpg)


